Bazinga! Another Priority Review Voucher Sold for $200 Million
There’s a lot of money to be made in pharmaceutical development and approvals; however, there’s another advantage to getting some products approved, even if they may not be as profitable as the firm had hoped. These are for drug products that are eligible for the award of a priority review voucher. The new Commissioner’s National […]

